Molina Healthcare, Inc. (MOH) Stock Price, News, Analysis

Technical Score (1D)

BUY

News Sentiment

MIXED

Molina Healthcare (MOH) has recently been the subject of positive developments, including finalized higher 2027 Medicare Advantage payment rates, which are influencing investor perceptions of government-backed health plans. This policy shift, coupled with billionaire investor Seth Klarman's new stake through Baupost Group, signals strong conviction from prominent investors. Baupost Group acquired over 620,000 shares, indicating a significant investment following Molina Healthcare's Q4 2025 earnings release. Despite these positive catalysts, the company's stock has experienced mixed performance, with recent short-term gains contrasting with a significant year-long decline. Analysts have also been revising price targets, with some lowering them while others maintain outperform ratings, highlighting ongoing scrutiny of valuation and margins. Molina Healthcare is reportedly considering special meetings to address these concerns and explore options to enhance shareholder value. Looking ahead, investors should monitor the impact of these community investments on member retention and brand reputation, as well as upcoming earnings reports for insights into future growth prospects. The company's business remains heavily reliant on state government Medicaid contracts, which constitute over 85% of its member base, making regulatory shifts and policy decisions critical factors to watch. Furthermore, the health insurance sector's profitability is sensitive to accurate risk assessment and medical cost control, with potential margin pressures from regulatory scrutiny and medical cost inflation.

Market Data

MOH Stock Snapshot

Molina Healthcare, Inc. · Healthcare · molinahealthcare.com

Molina Healthcare is a managed care provider specializing in government-sponsored healthcare programs. The company primarily serves low-income populations, offering health plans through Medicaid and Medicare programs across the United States. Molina's value proposition centers on delivering accessible and affordable healthcare solutions to vulnerable communities. Operating through four key segments Medicaid, Medicare, Marketplace, and Other the company has established a presence in the healthcare market since its founding in 1980. Headquartered in Long Beach, California, Molina Healthcare focuses on providing essential healthcare services to individuals and families who qualify for government assistance.

MOH is currently trading at $148.27, giving Molina Healthcare, Inc. a market cap of 7.76B and a P/E ratio of 16.4. Today's range spans $146.15–$151.00, with shares opening at $148.70 and moving down $0.71 (0.5%) from the prior close. DailyIQ's technical score sits at 77/100 (BUY) with a news sentiment reading of 50/100.

Over the past year MOH has traded between $121.06 and $340.88 - the current price is +22.5% off the 52-week low and -56.5% from the high. 25 analysts cover the stock with a Hold consensus and a mean 12-month target of $149.18 (range $109.00–$262.00), implying upside of +0.6%.

The bullish technical and neutral sentiment alignment for MOH is especially notable at the small-cap level. Score: 77/100 (BUY). Sentiment: 50/100. Price: $148.27 (near 52-week lows in $121.06–$340.88). The current P/E ratio stands at 16.4. With 7.76B in Healthcare market cap, the primary risk isn't the setup - it's execution. Small-cap Healthcare names with this kind of profile move fast once momentum builds, and the entry point matters more than it does at larger scales.

MOH|EarningsMolina Healthcare, Inc.

Earnings Summary

Molina Healthcare is a managed care provider specializing in government-sponsored healthcare programs, primarily serving low-income populations through Medicaid and Medicare. Operating in the Healthcare sector, within the Healthcare Plans industry, the company focuses on delivering accessible and affordable healthcare solutions to vulnerable communities across the United States. Molina Healthcare's recent quarterly performance has been marked by significant volatility in Earnings Per Share (EPS), with Q1 2026 EPS not yet reported, following a reported EPS of -2.75 in Q4 2025 against an estimate of $0.337, and $1.84 in Q3 2025 against an estimate of $3.89. Revenue, however, has shown more stability, with Q4 2025 revenue at $11.375 billion and Q3 2025 revenue at $11.477 billion. The company has experienced a pattern of missing analyst EPS estimates in recent quarters, notably in Q3 and Q4 2025, which contrasts with a beat in Q1 2025. Historically, Molina Healthcare's performance can be influenced by regulatory changes and the dynamics of government healthcare contracts. Recent news highlights positive developments such as finalized higher 2027 Medicare Advantage payment rates, which are expected to positively impact revenue outlook, and a new stake taken by Baupost Group, signaling investor confidence. Despite these catalysts, the stock has seen recent price weakness. Investors should monitor the impact of community investments on member retention, upcoming earnings reports for future growth prospects, and the critical influence of state government Medicaid contracts, which represent a significant portion of the member base. The company's profitability remains sensitive to risk assessment and medical cost control, with potential pressures from regulatory scrutiny and inflation.

Earnings | EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q1'26	$1.94	-	-
Q4'25	$0.34	$-2.75	-916.0%
Q3'25	$3.89	$1.84	-52.7%
Q2'25	$5.53	$5.48	-0.9%
Q1'25	$5.96	$6.08	+2.1%
Q4'24	$5.88	$5.05	-14.2%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q1'26	$10.9B	-	-
Q4'25	$11.0B	$11.4B	+3.7%
Q3'25	-	$11.5B	-
Q2'25	-	$11.4B	-
Q1'25	-	$11.1B	-
Q4'24	-	$10.5B	-

Technical Score (1D)

BUY

News Sentiment

MIXED

Market Data

MOH Stock Snapshot

Molina Healthcare, Inc. · Healthcare · molinahealthcare.com

News Sentiment Analysis

Sentiment gathered from recent headlines

50/100

Strong NegativeNeutralStrong Positive

MIXED

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

Molina Healthcare's (MOH) fair value estimates have seen a modest reduction, reflecting a recalibration of analyst expectations following a Q4 miss. Wall Street sentiment is divided, with some analysts believing current concerns are priced in, while others highlight ongoing execution risks and earnings visibility challenges. Policy shifts and medical cost trends are key factors influencing these divergent views.

What did this article say?

Argus Research has increased its price target for MOH to $140.00, reflecting a positive assessment of the company's prospects. This upward revision suggests continued confidence in MOH's strategic direction and operational performance. Traders should monitor management commentary for further insights into the drivers behind this target increase.

What did this article say?

Molina Healthcare, through its MolinaCares Accord, has awarded a $120,000 grant to Hebrew SeniorLife. This funding will bolster fitness and behavioral health programs within senior living communities. The initiative aims to enhance physical mobility, mental well-being, and social connections for residents by embedding services directly into their living environments. This investment underscores Molina's commitment to comprehensive care for seniors.

What did this article say?

Molina Healthcare (MOH) is under scrutiny following a recent share price decline, despite substantial revenue and net income figures. While short-term momentum has seen a slight uptick, the longer-term shareholder returns present a more challenging outlook. This volatility prompts a closer look at potential shifts in growth prospects and risk perception, especially as some data suggests a possible intrinsic discount.

What did this article say?

Molina Healthcare (MOH) is experiencing improved sentiment following the Centers for Medicare & Medicaid Services' finalized higher 2027 Medicare Advantage payment rates. This policy shift, coupled with billionaire investor Seth Klarman's new stake, is drawing attention to MOH's valuation and margins ahead of its Q1 2026 earnings. The developments underscore the impact of policy decisions on government-focused health insurers.

What did this article say?

Molina Healthcare operates medical insurance plans across Medicaid, individual exchanges, and Medicare, serving over 5 million individuals. The company's business is heavily reliant on state government contracts for its Medicaid programs, which constitute over 85% of its member base. A significant portion of enrollees, exceeding 50%, are concentrated in four key states: California, New York, Texas, and Washington.

What did this article say?

Molina Healthcare is reportedly considering special meetings, signaling potential strategic discussions around its current valuation and profit margins. This move comes as investors and analysts continue to scrutinize the company's financial performance and market positioning. The focus on these areas suggests management is actively addressing concerns and exploring options to enhance shareholder value. Traders should monitor any announcements regarding these meetings for insights into potential strategic shifts.

What did this article say?

Argus Research has lowered its price target for MOH to $127.00. This adjustment reflects a reassessment of the company's valuation in the current market environment. Investors should monitor future analyst commentary for further insights into the rationale behind this target revision.

What did this article say?

Molina Healthcare (MOH) is set to report its fiscal first-quarter 2026 earnings after market close on April 22. Analysts anticipate a significant year-over-year profit decline, with diluted EPS projected at $1.68, down from $6.08 in the prior year. This follows a pattern of mixed earnings surprises in recent quarters. Full-year 2026 EPS is also expected to decrease, though a substantial rebound is forecast for fiscal 2027.

What did this article say?

Multiple analysts have recently revised their price targets and ratings for Molina Healthcare (MOH). Deutsche Bank set a new target of $310.00, while UBS Group adjusted theirs to $173.00 and later to $151.00 with a neutral rating. Sanford C. Bernstein reaffirmed an outperform rating, contrasting with Mizuho's price target reduction to $180.00 but maintaining an outperform rating. Morgan Stanley and Wells Fargo & Company lowered their price targets and ratings, with Wells Fargo downgrading MOH from overweight to equal weight.

MOH|EarningsMolina Healthcare, Inc.

Earnings Summary

Earnings | EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q1'26	$1.94	-	-
Q4'25	$0.34	$-2.75	-916.0%
Q3'25	$3.89	$1.84	-52.7%
Q2'25	$5.53	$5.48	-0.9%
Q1'25	$5.96	$6.08	+2.1%
Q4'24	$5.88	$5.05	-14.2%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q1'26	$10.9B	-	-
Q4'25	$11.0B	$11.4B	+3.7%
Q3'25	-	$11.5B	-
Q2'25	-	$11.4B	-
Q1'25	-	$11.1B	-
Q4'24	-	$10.5B	-

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

MOH·Molina Healthcare, Inc.

MOH Stock Snapshot

Earnings | EPS

Revenue

MOH·Molina Healthcare, Inc.

MOH Stock Snapshot

News Sentiment Analysis

Recent News Coverage

Earnings | EPS

Revenue

News Sentiment Analysis

Recent News Coverage

MOH·Molina Healthcare, Inc.

MOH Stock Snapshot

Earnings | EPS

Revenue

MOH·Molina Healthcare, Inc.

MOH Stock Snapshot

News Sentiment Analysis

Recent News Coverage

Earnings | EPS

Revenue

Discover More

News Sentiment Analysis

Recent News Coverage

Discover More